65,437 trials
Kidney Transplantation
Primary: Number of Participants With First Clinical Biopsy Proven Acute Rejection (BPAR) Episode 6 Months Post-Transplant — 9; 11; 7 participants
Type 2 Diabetes Mellitus
Primary: Number of Patients With Treatment Failure — 203; 262; 287; 225 number of patients — p=0.0020
Colorectal Cancer
Primary: Response Rate (Percentage of Participants With Partial or Complete Response) — 63; 42 percentage of participants with response
Atrial Fibrillation
Primary: Percent of Patients Free From AF and Off Class I and III Anti-arrhythmic Drugs as Determined by Holter Monitoring at 6 Months. — 74 percentage of subjects
Lymphoma, Large-Cell, Diffuse · Lymphoma, B-Cell
Primary: Number of Patients Who Achieved Complete Response — 32 participants
Atrial Fibrillation
Primary: New Asymptomatic Cerebral Embolic Lesions, Visualized as 'Bright Spots' on Post-ablation MRI. — 1 participants
Methamphetamine Dependence · Substance Abuse · Methamphetamine Abuse
Primary: Change in MA Positive Urine Drug Screens Among Participants Randomly Assigned to Receive Varenicline Versus Placebo. — 7.4; 2.3 total MA-free urine drug screens
Asthma
Primary: Duration of Continuous Therapy — 18.3; 16 Hours
Heart Diseases · Arrhythmia · Atrial Fibrillation
Primary: The Percentage of Chronic Success of the NAVISTAR THERMOCOOL Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation (PAF) — 66; 16 Percentage of…
Dry Eye Syndromes
Primary: Change From Baseline in Ocular Surface Disease Index© Questionnaire Score — 41.48; 38.27; 40.28; 40.18 Score on a scale
Neoplasms
Primary: Percentage of Participants Who Achieved Pain Control — 84.0; 98.0 Percentage of Participants
Huntington Disease · Chorea · Executive Dysfunction
Primary: Executive Function Composite Score Comparing Visit 2 (Week 0) to Visits 5 (Week 12) & 6 (Week 15) for the Citalopram Cohort Versus Placebo Cohort. — 0.005; 0.172 units…
Carcinoma, Small Cell · Lung Cancer
Primary: Overall Response Rate (ORR), the Percentage of Patients Who Experience an Objective Benefit From Treatment — 19.6 percentage of participants
Tracheal Intubation · Laryngoscopy
Primary: Force Applied and Pressure Distribution Upon the Blade of Laryngoscopes During Tracheal Intubation. — 16; 10; 40; 8 Newton
Metastatic Pancreatic Cancer
Primary: Six-Month Overall Survival (OS) Probability, the Percentage of Patients Estimated to be Alive Six Months After Beginning Protocol Treatment — 37 percentage of participants